A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

Schlitt, B.

Paper Title Page
TUP054 Latest Commisioning Results of the Siemens Particle Therapy RFQ 530
 
  • S. Emhofer, O. Chubarov, I. Hollenborg, C.M. Kleffner, V.L. Lazarev, M.T. Maier, H. Rohdjess, B. Schlitt, T. Sieber, B. Steiner, P. Urschütz
    Siemens Med, Erlangen
  • H.K. Andersen, M. Budde, F. Bødker, J.S. Gretlund, H.B. Jeppesen, L. Kruse, C.V. Nielsen, C.G. Pedersen, Ka.T. Therkildsen, S.V. Weber
    Siemens DK, Jyllinge
  
 

Siemens is currently preparing, installing and commissioning three IONTRIS particle therapy accelerator systems - two in Germany, in Marburg and Kiel, and one in Shanghai, China. Siemens IONTRIS is based on a synchrotron to accelerate protons and carbon ions for clinical applications up to 250 MeV resp. 430 MeV/u. The injector part consists of an RFQ to accelerate protons and light ions up to 400 keV/u followed by an IH-cavity, wherein the particles achieve 7 MeV/u. The results of the commissioning of the RFQ in the test facility in Denmark will be presented.


*Particle Therapy is a work in progress and requires country-specific regulatory approval prior to clinical use.